Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospectiv...
Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data
About this item
Full title
Author / Creator
Publisher
Turkey: Türk Hematoloji Derneği
Journal title
Language
English
Formats
Publication information
Publisher
Turkey: Türk Hematoloji Derneği
Subjects
More information
Scope and Contents
Contents
This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients.
A total of 136 patients (mean age ± standard deviation: 64.6±10.3 years, 66.9% males) who had received at least one dose of ibrutinib were included in this retrospective multicenter,...
Alternative Titles
Full title
Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_506b9a34c2d64dd5beb096f766347808
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_506b9a34c2d64dd5beb096f766347808
Other Identifiers
ISSN
1300-7777
E-ISSN
1308-5263
DOI
10.4274/tjh.galenos.2021.2021.0007
